Access Resources
5151 - 5175 of 7540 Results
Title
Year
- RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease2018RESTRICTEDTitle: RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's diseaseJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 293Issue #: 28Start Page: 11047End Page: 11066Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.001747Best OA location URL: https://europepmc.org/articles/pmc6052236?pdf=renderCitation Count: 61
-
RESTRICTEDTitle: Subtype definition of vascular parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 107End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.005Best OA location URL: https://europepmc.org/articles/pmc6019183?pdf=renderCitation Count: 1
- Microstructural Changes in Patients With Parkinson's Disease Comorbid With REM Sleep Behaviour Disorder and Depressive Symptoms2018RESTRICTEDTitle: Microstructural Changes in Patients With Parkinson's Disease Comorbid With REM Sleep Behaviour Disorder and Depressive SymptomsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2018.00441Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2018.00441/pdfCitation Count: 14
-
RESTRICTEDTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 25
- Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson’s Disease and Cross-Cultural Comparison2018RESTRICTEDTitle: Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson’s Disease and Cross-Cultural ComparisonJournal Name: AssessmentPublisher: SAGE PublicationsVol: 27Issue #: 8Start Page: 1960End Page: 1970Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1073191118778896Best OA location URL: https://europepmc.org/articles/pmc6274600?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Cognitive Profiles and Hub Vulnerability in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2018.00482Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2018.00482/pdfCitation Count: 31
- Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation2018RESTRICTEDTitle: Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed ActivationJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 64Issue #: 2Start Page: 597End Page: 606Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-180121Best OA location URL: https://europepmc.org/articles/pmc6518401?pdf=renderCitation Count: 70
- Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries2018RESTRICTEDTitle: Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestriesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 6Start Page: e0198166End Page: e0198166Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0198166Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0198166&type=printableCitation Count: 80
- Somatic copy number gains of α-synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brains2018RESTRICTEDTitle: Somatic copy number gains of α-synuclein (SNCA) in Parkinson’s disease and multiple system atrophy brainsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 8Start Page: 2419End Page: 2431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awy157Best OA location URL: https://academic.oup.com/brain/article-pdf/141/8/2419/25219708/awy157.pdfCitation Count: 62
- Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy2018RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 5
- Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents2018RESTRICTEDTitle: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 8Issue #: 2Start Page: 303End Page: 322Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171248Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171248?id=journal-of-parkinsons-disease%2Fjpd171248Citation Count: 146
- Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysis2018RESTRICTEDTitle: Stratification of candidate genes for Parkinson’s disease using weighted protein-protein interaction network analysisJournal Name: BMC GenomicsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12864-018-4804-9Best OA location URL: https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/s12864-018-4804-9.pdfCitation Count: 35
-
RESTRICTEDTitle: Dual role of USP 30 in controlling basal pexophagy and mitophagyJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745595Best OA location URL: https://doi.org/10.15252/embr.201745595Citation Count: 116
-
RESTRICTEDTitle: Tau-targeting therapies for Alzheimer diseaseJournal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 7Start Page: 399End Page: 415Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41582-018-0013-zBest OA location URL: https://europepmc.org/articles/pmc6463489?pdf=renderCitation Count: 726
-
RESTRICTEDTitle: Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s modelsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 136Issue #: 4Start Page: 607End Page: 620Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-018-1873-4Best OA location URL: https://europepmc.org/articles/pmc6123262?pdf=renderCitation Count: 110
- Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure2018RESTRICTEDTitle: Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structureJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13073-018-0551-4Best OA location URL: https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-018-0551-4.pdfCitation Count: 46
-
RESTRICTEDTitle: Mechanism of parkin activation by PINK1Journal Name: NaturePublisher: Springer Science and Business Media LLCVol: 559Issue #: 7714Start Page: 410End Page: 414Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41586-018-0224-xBest OA location URL: https://europepmc.org/articles/pmc6071873?pdf=renderCitation Count: 245
- The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human2018RESTRICTEDTitle: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and humanJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 11Start Page: 1861End Page: 1883Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20180248Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/11/1861/691623/bcj-2018-0248.pdfCitation Count: 157
-
RESTRICTEDTitle: Tissue engineered nigrostriatal pathway for treatment of Parkinson's diseaseJournal Name: Journal of Tissue Engineering and Regenerative MedicinePublisher: Hindawi LimitedVol: 12Issue #: 7Start Page: 1702End Page: 1716Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/term.2698Best OA location URL: https://europepmc.org/articles/pmc6416379?pdf=renderCitation Count: 49
-
RESTRICTEDTitle: Association study of essential tremor genetic loci in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 66Issue #:Start Page: 178.e13End Page: 178.e15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.01.001Best OA location URL: http://escholarship.mcgill.ca/downloads/8336h617mCitation Count: 7
-
RESTRICTEDTitle: Gene Therapy Strategies to Restore ER Proteostasis in DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 26Issue #: 6Start Page: 1404End Page: 1413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2018.04.004Best OA location URL: https://doi.org/10.1016/j.ymthe.2018.04.004Citation Count: 34
- Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's disease2018RESTRICTEDTitle: Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 304Issue #:Start Page: 143End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.03.008Citation Count: 25
- Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?2018RESTRICTEDTitle: Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?Journal Name: ToxiconPublisher: Elsevier BVVol: 147Issue #:Start Page: 89End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.toxicon.2017.09.004Best OA location URL: https://europepmc.org/articles/pmc5839920?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: mGlu4 allosteric modulation for treating Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 135Issue #:Start Page: 308End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.03.027Citation Count: 25
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study2018RESTRICTEDTitle: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 548End Page: 558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1Best OA location URL: http://www.thelancet.com/article/S1474442218301261/pdfCitation Count: 94